Aaron Wealth Advisors LLC Has $2.43 Million Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Aaron Wealth Advisors LLC boosted its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 18.9% during the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 4,150 shares of the healthcare conglomerate’s stock after buying an additional 661 shares during the period. Aaron Wealth Advisors LLC’s holdings in UnitedHealth Group were worth $2,426,000 at the end of the most recent reporting period.

Other institutional investors have also bought and sold shares of the company. Kathleen S. Wright Associates Inc. acquired a new position in UnitedHealth Group in the third quarter worth $27,000. Global Wealth Strategies & Associates boosted its stake in UnitedHealth Group by 152.4% in the third quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock worth $31,000 after purchasing an additional 32 shares in the last quarter. Macroview Investment Management LLC boosted its stake in UnitedHealth Group by 671.4% in the second quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock worth $28,000 after purchasing an additional 47 shares in the last quarter. West Financial Advisors LLC acquired a new position in UnitedHealth Group in the third quarter worth $32,000. Finally, Delos Wealth Advisors LLC boosted its stake in UnitedHealth Group by 757.1% in the first quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock worth $30,000 after purchasing an additional 53 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Trading Up 0.3 %

Shares of UnitedHealth Group stock traded up $1.45 during trading hours on Friday, hitting $567.48. The company’s stock had a trading volume of 993,350 shares, compared to its average volume of 3,953,154. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $608.63. The stock has a 50 day moving average of $584.20 and a 200 day moving average of $533.07. The company has a market capitalization of $524.02 billion, a PE ratio of 37.53, a price-to-earnings-growth ratio of 1.69 and a beta of 0.58. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.88 and a quick ratio of 0.88.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.00 by $0.15. The business had revenue of $100.82 billion during the quarter, compared to the consensus estimate of $99.14 billion. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. UnitedHealth Group’s quarterly revenue was up 9.2% on a year-over-year basis. During the same period last year, the company earned $6.56 earnings per share. Analysts predict that UnitedHealth Group Incorporated will post 27.68 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 24th. Investors of record on Monday, September 16th were issued a dividend of $2.10 per share. The ex-dividend date was Monday, September 16th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.48%. UnitedHealth Group’s payout ratio is presently 55.70%.

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on the company. UBS Group cut their price target on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating on the stock in a research note on Wednesday. StockNews.com raised UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Wednesday. Stephens cut their price target on UnitedHealth Group from $632.00 to $605.00 and set an “overweight” rating on the stock in a research note on Wednesday. KeyCorp assumed coverage on UnitedHealth Group in a research note on Friday, October 11th. They set an “overweight” rating and a $675.00 price target on the stock. Finally, Truist Financial reiterated a “buy” rating and issued a $625.00 price objective (down previously from $640.00) on shares of UnitedHealth Group in a report on Wednesday. Two equities research analysts have rated the stock with a hold rating, eighteen have given a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat, the stock has a consensus rating of “Buy” and an average price target of $615.16.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.